Identification and rational redesign of peptide ligands to CRIP1, a novel biomarker for cancers

Jihua Hao, Adrian W.R. Serohijos, Gail Newton, Gina Tassone, Zuncai Wang, Dennis C. Sgroi, Nikolay V. Dokholyan, James P. Basilion

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Cysteine-rich intestinal protein 1 (CRIP1) has been identified as a novel marker for early detection of cancers. Here we report on the use of phage display in combination with molecular modeling to identify a high-affinity ligand for CRIP1. Panning experiments using a circularized C7C phage library yielded several consensus sequences with modest binding affinities to purified CRIP1. Two sequence motifs, A1 and B5, having the highest affinities for CRIP1, were chosen for further study. With peptide structure information and the NMR structure of CRIP1, the higher-affinity A1 peptide was computationally redesigned, yielding a novel peptide, A1M, whose affinity was predicted to be much improved. Synthesis of the peptide and saturation and competitive binding studies demonstrated approximately a 10-28-fold improvement in the affinity of A1M compared to that of either A1 or B5 peptide. These techniques have broad application to the design of novel ligand peptides.

Original languageEnglish (US)
Article numbere1000138
JournalPLoS computational biology
Volume4
Issue number8
DOIs
StatePublished - Aug 1 2008

Fingerprint

Biomarkers
Tumor Biomarkers
Peptides
peptide
ligand
Affine transformation
Cysteine
cysteine
biomarker
cancer
biomarkers
Cancer
Ligands
peptides
Proteins
Protein
neoplasms
protein
Bacteriophages
proteins

All Science Journal Classification (ASJC) codes

  • Ecology, Evolution, Behavior and Systematics
  • Modeling and Simulation
  • Ecology
  • Molecular Biology
  • Genetics
  • Cellular and Molecular Neuroscience
  • Computational Theory and Mathematics

Cite this

Hao, J., Serohijos, A. W. R., Newton, G., Tassone, G., Wang, Z., Sgroi, D. C., ... Basilion, J. P. (2008). Identification and rational redesign of peptide ligands to CRIP1, a novel biomarker for cancers. PLoS computational biology, 4(8), [e1000138]. https://doi.org/10.1371/journal.pcbi.1000138
Hao, Jihua ; Serohijos, Adrian W.R. ; Newton, Gail ; Tassone, Gina ; Wang, Zuncai ; Sgroi, Dennis C. ; Dokholyan, Nikolay V. ; Basilion, James P. / Identification and rational redesign of peptide ligands to CRIP1, a novel biomarker for cancers. In: PLoS computational biology. 2008 ; Vol. 4, No. 8.
@article{7afa7376ed11454c93c46755dea55023,
title = "Identification and rational redesign of peptide ligands to CRIP1, a novel biomarker for cancers",
abstract = "Cysteine-rich intestinal protein 1 (CRIP1) has been identified as a novel marker for early detection of cancers. Here we report on the use of phage display in combination with molecular modeling to identify a high-affinity ligand for CRIP1. Panning experiments using a circularized C7C phage library yielded several consensus sequences with modest binding affinities to purified CRIP1. Two sequence motifs, A1 and B5, having the highest affinities for CRIP1, were chosen for further study. With peptide structure information and the NMR structure of CRIP1, the higher-affinity A1 peptide was computationally redesigned, yielding a novel peptide, A1M, whose affinity was predicted to be much improved. Synthesis of the peptide and saturation and competitive binding studies demonstrated approximately a 10-28-fold improvement in the affinity of A1M compared to that of either A1 or B5 peptide. These techniques have broad application to the design of novel ligand peptides.",
author = "Jihua Hao and Serohijos, {Adrian W.R.} and Gail Newton and Gina Tassone and Zuncai Wang and Sgroi, {Dennis C.} and Dokholyan, {Nikolay V.} and Basilion, {James P.}",
year = "2008",
month = "8",
day = "1",
doi = "10.1371/journal.pcbi.1000138",
language = "English (US)",
volume = "4",
journal = "PLoS Computational Biology",
issn = "1553-734X",
publisher = "Public Library of Science",
number = "8",

}

Identification and rational redesign of peptide ligands to CRIP1, a novel biomarker for cancers. / Hao, Jihua; Serohijos, Adrian W.R.; Newton, Gail; Tassone, Gina; Wang, Zuncai; Sgroi, Dennis C.; Dokholyan, Nikolay V.; Basilion, James P.

In: PLoS computational biology, Vol. 4, No. 8, e1000138, 01.08.2008.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Identification and rational redesign of peptide ligands to CRIP1, a novel biomarker for cancers

AU - Hao, Jihua

AU - Serohijos, Adrian W.R.

AU - Newton, Gail

AU - Tassone, Gina

AU - Wang, Zuncai

AU - Sgroi, Dennis C.

AU - Dokholyan, Nikolay V.

AU - Basilion, James P.

PY - 2008/8/1

Y1 - 2008/8/1

N2 - Cysteine-rich intestinal protein 1 (CRIP1) has been identified as a novel marker for early detection of cancers. Here we report on the use of phage display in combination with molecular modeling to identify a high-affinity ligand for CRIP1. Panning experiments using a circularized C7C phage library yielded several consensus sequences with modest binding affinities to purified CRIP1. Two sequence motifs, A1 and B5, having the highest affinities for CRIP1, were chosen for further study. With peptide structure information and the NMR structure of CRIP1, the higher-affinity A1 peptide was computationally redesigned, yielding a novel peptide, A1M, whose affinity was predicted to be much improved. Synthesis of the peptide and saturation and competitive binding studies demonstrated approximately a 10-28-fold improvement in the affinity of A1M compared to that of either A1 or B5 peptide. These techniques have broad application to the design of novel ligand peptides.

AB - Cysteine-rich intestinal protein 1 (CRIP1) has been identified as a novel marker for early detection of cancers. Here we report on the use of phage display in combination with molecular modeling to identify a high-affinity ligand for CRIP1. Panning experiments using a circularized C7C phage library yielded several consensus sequences with modest binding affinities to purified CRIP1. Two sequence motifs, A1 and B5, having the highest affinities for CRIP1, were chosen for further study. With peptide structure information and the NMR structure of CRIP1, the higher-affinity A1 peptide was computationally redesigned, yielding a novel peptide, A1M, whose affinity was predicted to be much improved. Synthesis of the peptide and saturation and competitive binding studies demonstrated approximately a 10-28-fold improvement in the affinity of A1M compared to that of either A1 or B5 peptide. These techniques have broad application to the design of novel ligand peptides.

UR - http://www.scopus.com/inward/record.url?scp=50949117526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50949117526&partnerID=8YFLogxK

U2 - 10.1371/journal.pcbi.1000138

DO - 10.1371/journal.pcbi.1000138

M3 - Article

C2 - 18670594

AN - SCOPUS:50949117526

VL - 4

JO - PLoS Computational Biology

JF - PLoS Computational Biology

SN - 1553-734X

IS - 8

M1 - e1000138

ER -